• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    UpHealth Appoints Sarah Arnquist as Senior Vice President of the Behavioral Health Business

    10/20/21 9:27:00 PM ET
    $UPH
    Retail: Computer Software & Peripheral Equipment
    Technology
    Get the next $UPH alert in real time by email

    DELRAY BEACH, Fla., Oct. 20, 2021 /PRNewswire/ -- UpHealth, Inc., (NYSE:UPH) has appointed an experienced health care executive, Sarah Arnquist, to its senior leadership team. Arnquist who joined UpHealth effective immediately, will serve as senior vice president of the Behavioral Health Business.

    (PRNewsfoto/UpHealth, Inc.)

    Arnquist is an experienced health care executive with deep understanding of Medicaid policy and delivery systems, especially in the Western U.S. In her role at UpHealth, she will focus on expanding its offerings to health plans and healthcare providers with technology platforms and innovative models to manage behavioral health. Her initial priority will be in California around CalAIM and the integration of medical, behavioral health and social services.

    "Sarah brings deep experience to UpHealth on innovative care models to address the needs of patients with complex conditions and specifically on the integration of medical care and behavioral health," said Ramesh Balakrishnan, CEO of UpHealth. "She understands the operational side of behavioral health, facilitating 'whole-health' and mental well-being for vulnerable patient populations. Her track record launching programs at scale is invaluable, and we look forward to her contributions to the continued expansion of UpHealth's solutions and customers." 

    UpHealth's approach to behavioral health is about purpose and impact. The clinical teams running behavioral health programs across residential, out-patient and telehealth settings have developed deep expertise managing behavioral health across the acuity continuum. Arnquist and her team will work with UpHealth's technology and integrated behavioral health team to help manage behavioral health programs for its customers and expand beyond delivery of services to become a partner to organizations managing behavioral health programs.

    Arnquist joins UpHealth from Beacon Health Options, where she led account management for the entire Western Region. Prior to Beacon, she worked as a health policy consultant; as a value-based health care services researcher at Harvard's School of Public Health. She holds an MPH from Johns Hopkins Bloomberg School of Public Health where she focused on policy and economics.

    About UpHealth, Inc.

    UpHealth is a global digital health company that delivers digital-first technology, infrastructure and services to dramatically improve how healthcare is delivered and managed. The UpHealth platform creates digitally enabled "care communities" that improve access and achieve better patient outcomes at lower cost, through digital health solutions and interoperability tools that serve patients wherever they are, in their native language. UpHealth's clients include global governments, health plans, healthcare providers and community-based organizations.

    For more information, please visit https://uphealthinc.com and follow us at @UpHealthInc on Twitter, UpHealth Inc. on LinkedIn and @uphealthinc on Instagram.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding our management team's expectations, hopes, beliefs, intentions, plans, prospects or strategies regarding the future, including revenue growth and financial performance, product expansion and services. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are based on our management team's current expectations and beliefs in light of their collective experience and their perception of historical trends, current conditions and expected future developments and their potential effects on UpHealth as well as other factors they believe are appropriate in the circumstances. There can be no assurance that future developments affecting UpHealth will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, including regulatory approvals, the ability of UpHealth to continue to meet the NYSE listing standards, product and service acceptance, and that UpHealth will have sufficient capital to operate as anticipated. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Additional factors that could cause actual results to differ are discussed under the heading "Risk Factors" and in other sections of UpHealth's filings with the SEC, and in UpHealth's current and periodic reports filed or furnished from time to time with the SEC. All forward-looking statements in this press release are made as of the date hereof, based on information available to UpHealth as of the date hereof, and UpHealth assumes no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/uphealth-appoints-sarah-arnquist-as-senior-vice-president-of-the-behavioral-health-business-301405263.html

    SOURCE UpHealth, Inc.

    Get the next $UPH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $UPH

    DatePrice TargetRatingAnalyst
    3/31/2022$6.00 → $1.00Buy → Hold
    Lake Street
    10/25/2021$6.00Buy
    Lake Street
    7/22/2021$12.00Outperform
    Oppenheimer
    7/13/2021$13.00Outperform
    Northland Capital
    More analyst ratings

    $UPH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • UpHealth Announces CEO Transition and Organizational Changes

      Jay Jennings Appointed Acting Chief Executive Officer of UpHealth; Replacing Martin Beck Announces the Promotion of Lisa Fluxman to President of TTC Healthcare Reaffirms Jeremy Livianu as Chief Legal Officer and Secretary of UpHealth DELRAY BEACH, Fla., July 15, 2024 /PRNewswire/ -- UpHealth, Inc. ("UpHealth," the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced the July 11, 2024 appointment by the Board of Directors of the Company of Jay Jennings, currently the Company's Chief Financial Officer, to serve as the Company's Acting Chief Executive Officer, replac

      7/15/24 4:15:00 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • The International Court of Arbitration awarded UpHealth Holdings more than $110 Million in Damages in Breach of Contract Lawsuit Involving the 2020 Purchase by UpHealth of Glocal Healthcare Systems

      DELRAY BEACH, Fla., March 20, 2024 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("UpHealth") (OTC:UPHL), a global digital health company delivering a full continuum of behavioral health solutions through the utilization of evidence-based treatments and services, today provided an update on the arbitration brought by UpHealth Holdings, Inc., a wholly-owned direct subsidiary of UpHealth ("Holdings"), against Glocal Healthcare Systems ("Glocal") and several of Glocal's officers and shareholders (together with Glocal, the "Respondents"). On March 18, 2024, the International Court of Arbitration of the International Chamber of Commerce (the "ICA") transmitted the Final Award to the parties. In the Final

      3/20/24 5:00:04 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • UpHealth Completes Sale of Cloudbreak Health at $180 Million Full Cash Deal

      DELRAY BEACH, Fla., March 18, 2024 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("we," "our," "UpHealth," or the "Company") (NYSE:UPHL) today announced that it completed its previously announced sale of Cloudbreak Health, LLC ("Cloudbreak"), best known for its Martti™ translation offering, to a newly formed entity controlled by GTCR LLC for $180 million in gross cash proceeds on March 15, 2024. The $180 million in gross proceeds will be used to pay all closing expenses including any potential liability for taxes on the sale and paying down the Company's debt, including all of the Company's $115 million 2026 Notes and a substantial portion of its $57.2 million 2025 Notes. "This transaction is one m

      3/18/24 8:30:10 AM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology

    $UPH
    SEC Filings

    See more
    • SEC Form DEFA14A filed by UpHealth Inc.

      DEFA14A - UpHealth, Inc. (0001770141) (Filer)

      2/15/24 4:48:59 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • UpHealth Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement

      8-K - UpHealth, Inc. (0001770141) (Filer)

      2/15/24 4:44:09 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form DEFM14A filed by UpHealth Inc.

      DEFM14A - UpHealth, Inc. (0001770141) (Filer)

      1/24/24 6:06:58 AM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology

    $UPH
    Financials

    Live finance-specific insights

    See more
    • UpHealth Announces Second Quarter 2023 Financial Results

      Second Quarter Revenues Were $37.8 million and Gross Margin Expanded to 53% Year-to-Date Net Loss Attributable to UpHealth, Inc. Improved 9% to $27.2 million Year-to-Date Adjusted EBITDA Improved by $9.2 million to $11.8 million Closed Strategic Sale of Innovations Group, Inc. for $56.0 million Completed Repurchase of $10.3 Million of Convertible Debt Increasing Full Year 2023 Outlook DELRAY BEACH, Fla., Aug. 10, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("UpHealth" or the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced financi

      8/10/23 4:15:05 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • UpHealth Announces Timing of Second Quarter 2023 Earnings Release and Conference Call

      DELRAY BEACH, Fla., July 25, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. (NYSE:UPH) ("UpHealth" or the "Company"), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced that it will release financial results for its second quarter ended June 30, 2023, after market close on Thursday, August 10, 2023. A conference call to discuss the results will follow at 5:00 p.m. Eastern Time on the same day. Those wishing to participate via the webcast should access the call through UpHealth's Investor Relations website at https://investors.uphealthinc.com. Those wishing to participate via the telep

      7/25/23 8:30:00 AM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • UpHealth Announces First Quarter 2023 Financial Results

      First Quarter Revenues Increased 17% to $42.1 millionFirst Quarter Gross Margin Expanded to 54% First Quarter Net Loss Attributable to UpHealth, Inc. Decreased 54% to $8.1 millionFirst Quarter Adjusted EBITDA Improved by $7.9 million to $6.6 million Announced Strategic Sale of Innovations Group, Inc. for $56.0 million DELRAY BEACH, Fla., May 11, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("UpHealth" or the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced financial results for the first quarter ended March 31, 2023. UpHealth Chief Executive Officer Sam Meckey

      5/11/23 4:08:05 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology

    $UPH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by UpHealth Inc. (Amendment)

      SC 13D/A - UpHealth, Inc. (0001770141) (Subject)

      11/29/23 4:03:50 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form SC 13D/A filed by UpHealth Inc. (Amendment)

      SC 13D/A - UpHealth, Inc. (0001770141) (Subject)

      11/27/23 8:34:32 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form SC 13D filed by UpHealth Inc.

      SC 13D - UpHealth, Inc. (0001770141) (Subject)

      11/27/23 8:20:19 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology

    $UPH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Beck Martin S A

      4 - UpHealth, Inc. (0001770141) (Issuer)

      2/15/24 4:29:53 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form 4 filed by Locke Nathan

      4 - UpHealth, Inc. (0001770141) (Issuer)

      2/2/24 6:24:51 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Greene James S was granted 100,000 shares (SEC Form 4)

      4 - UpHealth, Inc. (0001770141) (Issuer)

      2/2/24 6:23:53 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology

    $UPH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • UpHealth downgraded by Lake Street with a new price target

      Lake Street downgraded UpHealth from Buy to Hold and set a new price target of $1.00 from $6.00 previously

      3/31/22 8:59:33 AM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Lake Street initiated coverage on UpHealth with a new price target

      Lake Street initiated coverage of UpHealth with a rating of Buy and set a new price target of $6.00

      10/25/21 9:33:22 AM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Oppenheimer initiated coverage on UpHealth with a new price target

      Oppenheimer initiated coverage of UpHealth with a rating of Outperform and set a new price target of $12.00

      7/22/21 7:07:38 AM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology

    $UPH
    Leadership Updates

    Live Leadership Updates

    See more
    • UpHealth Announces CEO Transition and Organizational Changes

      Jay Jennings Appointed Acting Chief Executive Officer of UpHealth; Replacing Martin Beck Announces the Promotion of Lisa Fluxman to President of TTC Healthcare Reaffirms Jeremy Livianu as Chief Legal Officer and Secretary of UpHealth DELRAY BEACH, Fla., July 15, 2024 /PRNewswire/ -- UpHealth, Inc. ("UpHealth," the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced the July 11, 2024 appointment by the Board of Directors of the Company of Jay Jennings, currently the Company's Chief Financial Officer, to serve as the Company's Acting Chief Executive Officer, replac

      7/15/24 4:15:00 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • UpHealth Announces CEO Transition and Organizational Changes

      Martin Beck Appointed CEO, Replacing Samuel Meckey Announces the Elimination of 20 Corporate Roles DELRAY BEACH, Fla., Oct. 11, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("UpHealth," the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced the October 5, 2023 appointment by the Board of Directors of the Company of Martin Beck to serve as the Company's next Chief Executive Officer, replacing Samuel Meckey, effective October 6, 2023, and Mr. Beck being named as a member of the Board of Directors effective October 9, 2023. Mr. Beck has been UpHealth's Chie

      10/11/23 8:30:00 AM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • UpHealth Announces Results of First Annual Stockholder Meeting

      Proposed New Independent Board Members Elected Stockholders Approved Reverse Split of the Company's Shares Stockholders Approve New Independent Auditor DELRAY BEACH, Fla., Dec. 05, 2022 (GLOBE NEWSWIRE) -- UpHealth, Inc. (NYSE:UPH) announces the results of its first annual stockholder meeting, held December 5, 2022, virtually. All resolutions submitted for stockholder approval were adopted, including the following: Election of three Class I directors to hold office until the 2025 annual meeting and until their respective successors are elected and qualified.Approval of reverse stock split.Ratification of the appointment of BPM LLP as independent registered public accountin

      12/5/22 4:11:00 PM ET
      $COLB
      $UMPQ
      $UPH
      Savings Institutions
      Finance
      Commercial Banks
      Retail: Computer Software & Peripheral Equipment